SCHEMBL6983183

SCHEMBL6983183

CCCCOc1cc2c(=O)c(Cc3cccnc3)cn3c4ccc(Br)cc4c(c1)c23

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 1/20 0.37
CNR2 P34972 1/20 0.37
GABRA1 P14867 1/20 0.36
GABRA5 P31644 1/20 0.36
KCNA5 P22460 4/20 0.36
GRM2 Q14416 2/20 0.36
CYP2C9 P11712 4/20 0.35
CYP2C19 P33261 4/20 0.35
CYP3A4 P08684 3/20 0.35
CYP2D6 P10635 3/20 0.35
CYP19A1 P11511 1/20 0.35
CYP1A2 P05177 3/20 0.35
TSHR P16473 3/20 0.35
HTT P42858 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
KCNJ5 P48544 1/20 0.34
KCNJ3 P48549 1/20 0.34
LMNA P02545 2/20 0.34
KMT2A Q03164 2/20 0.34
MEN1 O00255 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6983481 0.92 GABRA1 (0.38) CNR1CNR2GABRA1GABRA5CYP2C9
SCHEMBL6978829 0.91 GABRA1 (0.36) GABRA1GABRA5KCNA5GRM2CYP2C9
SCHEMBL6975815 0.91 LMNA (0.36) CNR1CNR2TSHRSMN1; SMN2LMNA
SCHEMBL6983106 0.90 TSHR (0.35) GABRA1GABRA5GRM2CYP2C9CYP3A4
SCHEMBL6979179 0.89 GABRA1 (0.39) GABRA1GABRA5GRM2CYP2C9CYP2C19
SCHEMBL6975197 0.88 ALDH1A1 (0.36) CNR1CNR2GABRA1GABRA5CYP2C9
SCHEMBL6977175 0.88 GABRA1 (0.39) CNR1CNR2GABRA1GABRA5CYP2C9
SCHEMBL7674357 0.88 GABRA1 (0.36) GABRA1GABRA5KCNA5CYP2C9CYP2C19
SCHEMBL6982487 0.88 LRRK2 (0.38) GABRA1GABRA5GRM2CYP2C9CYP2C19
SCHEMBL6981489 0.87 FPR1 (0.36) GABRA1GABRA5CYP2C9CYP2C19CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0985671-B1 PYRIDOCARBAZOLE DERIVATIVES HAVING cGMP-PDE INHIBITORY EFFECT MOCHIDA PHARM CO LTD (JP) 2003-04-02 EP disclosed
US-6197768-B1 THERAPY, PREVENTION ISCHEMIC HEART DISEASE MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2001-03-06 US disclosed
EP-0985671-A1 PYRIDOCARBAZOLE DERIVATIVES HAVING cGMP-PDE INHIBITORY EFFECT MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2000-03-15 EP disclosed
US-6018046-A SELECTIVE ACTION IN INHIBITING CYCLIC GMP-PHOSPHODIESTERASE (CGMP-PDE); PHARMACEUTICALS FOR TREATING DISEASES AGAINST WHICH THE INHIBITORY ACTION IS EFFECTIVE, SUCH AS PULMONARY HYPERTENSION MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2000-01-25 US disclosed